Sandeep Tandon of Quant Mutual Fund sees India’s market setup as constructive, recommending continued exposure to IT, pharma, and FMCG. IT stocks may outperform over 6–12 months, while GST-led consumption and global demand support pharma and FMCG growth, backed by steady retail inflows.